No profile data available.
Axogen, Inc. (AXGN) is a healthcare company in the targeted healthcare equipment industry, based in Alachua, United States, with about 622 full-time employees.
It reported revenue of $225.21 million for fiscal year 2025, up 20.2% from fiscal year 2024, and net income of -$15.70 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $61.46 million, up 26.6% from a year before. Its market capitalization was $2.12 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide.
Axogen reported $225.21 million in revenue for fiscal year 2025, up 20.2% from $187.34 million in fiscal year 2024. In Q1 2026 revenue was $61.46 million.
$2.12 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include The Cooper Companies, Inc. (COO), Glaukos Corporation (GKOS), Lantheus Holdings, Inc. (LNTH), Inspire Medical Systems, Inc. (INSP).